Peter Smith

Company: Remix Therapeutics
Job title: Co-Founder, President & CEO
Seminars:
Biopharma & Investment Partnerships Panel — Exploring the Future of RNA Investment & Collaborations Space for Small Molecules 11:00 am
The biopharmaceutical sector is considering small molecule medications as a vital component. This community thrives on strategic alliances, which allow for cross-functional sharing of knowledge, skills, and experience across different disciplines to truly advance RNA-targeted small molecule drugs to patients. This session is the ideal opportunity to get face-to-face time with many of the brightest…Read more
day: Day One
Novel Approaches to Reprogram RNA Processing with Small Molecules 9:00 am
Recognizing data science techniques for RNA processing variation analysis in genomic data Using small molecules as research tools in RNA processing Exploiting therapeutic intervention possibilitiesRead more
day: Day One